Annual report pursuant to Section 13 and 15(d)

JOINT VENTURE AND OPTIONS TRANSACTION (Details)

v3.21.2
JOINT VENTURE AND OPTIONS TRANSACTION (Details) - USD ($)
 3 Months Ended 12 Months Ended
Jun. 14, 2021
Mar. 01, 2020
Dec. 23, 2019
Jun. 24, 2019
Feb. 04, 2019
Jan. 29, 2019
Oct. 31, 2018
Aug. 31, 2021
May 31, 2021
May 31, 2020
JOINT VENTURE AND OPTIONS TRANSACTION (Details) [Line Items]                    
Financing Receivable, after Allowance for Credit Loss, Current             $ 5,000,000   $ 0  
Note Receivable, Interest Rate, Stated Percentage             6.00%      
Interest Costs Capitalized                 212,601 $ 1,553,082
Proceeds from Collection of Notes Receivable                 1,544,291 1,682,278
Asset Impairment Charges                 2,498,706 0
Interest Receivable, Current                 0 3,322
Payments to Acquire Notes Receivable                 0 175,000
Subsequent Event [Member]                    
JOINT VENTURE AND OPTIONS TRANSACTION (Details) [Line Items]                    
Financing Receivable, after Allowance for Credit Loss, Current $ 3,000,000                  
Proceeds from Collection of Notes Receivable 2,000,000                  
Proceeds from Sale and Collection of Notes Receivable               $ 1,167,000    
Financing Receivable, after Allowance for Credit Loss 3,000,000                  
Due and Payable on or Before June 21, 2021 [Member] | Subsequent Event [Member]                    
JOINT VENTURE AND OPTIONS TRANSACTION (Details) [Line Items]                    
Proceeds from Collection of Notes Receivable 500,000                  
Due and Payable on or Before July 12, 2021 [Member] | Subsequent Event [Member]                    
JOINT VENTURE AND OPTIONS TRANSACTION (Details) [Line Items]                    
Proceeds from Collection of Notes Receivable 500,000                  
Due and Payable in 12 Monthly Installments [Member] | Subsequent Event [Member]                    
JOINT VENTURE AND OPTIONS TRANSACTION (Details) [Line Items]                    
Proceeds from Collection of Notes Receivable $ 2,000,000                  
In Good Health [Member]                    
JOINT VENTURE AND OPTIONS TRANSACTION (Details) [Line Items]                    
Business Combination, Consideration Transferred             $ 47,500,000      
Payments to Acquire Businesses, Gross             35,000,000      
Business Combination, Consideration Transferred, Liabilities Incurred             7,500,000      
Interest Income, Related Party                 149,972 296,450
Interest Costs Capitalized   $ 399,453             0 399,453
Proceeds from Collection of Notes Receivable                 1,696,765 1,425,000
Option Agreement, Brake-Up Fee             $ 2,500,000      
Interest Rate, Default             15.00%      
Asset Impairment Charges                 2,498,706  
Joint Venture with CannAssist [Member]                    
JOINT VENTURE AND OPTIONS TRANSACTION (Details) [Line Items]                    
Interest Income, Related Party                 0 14,673
Proceeds from Collection of Notes Receivable     $ 342,567              
Debt Instrument, Face Amount           $ 500,000        
Line of Credit Facility, Description           Any draws on the line of credit in excess of $150,000 will only be made in the sole discretion of the Company        
Debt Instrument, Interest Rate, Stated Percentage           8.00%        
Payments to Acquire Notes Receivable       $ 175,000 $ 150,000          
Financing Receivable, after Allowance for Credit Loss       $ 325,000            
Principal [Member] | In Good Health [Member]                    
JOINT VENTURE AND OPTIONS TRANSACTION (Details) [Line Items]                    
Proceeds from Collection of Notes Receivable                 1,544,291 1,357,278
Asset Impairment Charges                 2,497,884  
Principal [Member] | Joint Venture with CannAssist [Member]                    
JOINT VENTURE AND OPTIONS TRANSACTION (Details) [Line Items]                    
Proceeds from Collection of Notes Receivable     325,000              
Accrued Interest [Member] | In Good Health [Member]                    
JOINT VENTURE AND OPTIONS TRANSACTION (Details) [Line Items]                    
Proceeds from Collection of Notes Receivable                 152,473 $ 67,722
Asset Impairment Charges                 $ 822  
Accrued Interest [Member] | Joint Venture with CannAssist [Member]                    
JOINT VENTURE AND OPTIONS TRANSACTION (Details) [Line Items]                    
Proceeds from Collection of Notes Receivable     $ 17,567              
Option Agreement [Member] | In Good Health [Member]                    
JOINT VENTURE AND OPTIONS TRANSACTION (Details) [Line Items]                    
Business Combination, Consideration Transferred             $ 47,500,000      
Payments to Acquire Businesses, Gross             35,000,000      
Business Combination, Consideration Transferred, Liabilities Incurred             7,500,000      
Business Combination, Consideration Transferred, Other             $ 2,500,000      
Debt Instrument, Term             5 years      
Option Agreement [Member] | Restricted Stock [Member] | In Good Health [Member]                    
JOINT VENTURE AND OPTIONS TRANSACTION (Details) [Line Items]                    
Equity Issued in Business Combination, Fair Value Disclosure             $ 5,000,000